🇺🇸 FDA
Patent

US 7964217

Degradable poly(ethylene glycol) hydrogels with controlled half-life and precursors therefor

granted A61KA61K47/10A61K47/34

Quick answer

US patent 7964217 (Degradable poly(ethylene glycol) hydrogels with controlled half-life and precursors therefor) held by Nektar Therapeutics expires Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Nektar Therapeutics
Grant date
Tue Jun 21 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K47/10, A61K47/34